IRCT2015070423046N1已完成3 期
The Effect of Adjuvant IMOD therapy on the Immunological Status of HIV-positive Patients: A Random Controlled Clinical Trial
Vice chancellor for research Of Qom Branch Of Islamic Azad University - Counseling Center for Behavi0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •HIV-positive patients (with two positive ELISA tests and a positive Western blot test) with Indications for treatment with HAART regimen
- •Exclusion criteria: The patient withdrew from the study of cooperation
排除标准
- 未提供
研究者
相似试验
尚未招募
3 期
Effect of new remedy IMOD [Immunomodulating drug ] on the mortality of patients with severe sepsis. A phase III multicenter studyInflammatory and Immune System - Rheumatoid arthritissepsisACTRN12609000001291pars rus60
尚未招募
1 期
Gastric cancer immunotherapyIRCT20170208032451N1Mashhad University of Medical Sciences5
尚未招募
2 期
Evaluating the effect of new remedy IMOD (Imunomodulating Drug)in the treatment of adult patients with sever sepsisACTRN12607000376448Tehran University of Medical Sciences,faculty of pharmacy25
已完成
2 期
ImmunoModulation effects of early therapeutic NORMothermia in febrile severe Septic patientstherapeutic normothermiafever controlimmunomodulationneutrophil chemotaxiscytokinesCD11bmHLA-SepsissepsisDRTCTR20160321001Faculty of Medicine, Chulalongkorn University15
已完成
不适用
Clinical study of adjuvant immuno-cell therapy for pancreatic cancer curatively resectable.Pancreatic cancerJPRN-C000000414Yokohama City University Hospital10